A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations
Clinical trial NCT05766709 · COMPLETED
Trial details
- NCT number
- NCT05766709
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-02
- Primary completion
- 2024-01-05
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.